Anas Younes Selected Research

Lymphoma (Lymphomas)

1/2022	Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
1/2022	Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.
1/2021	Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition.
1/2021	Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
1/2020	Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
1/2019	Emerging epigenetic-modulating therapies in lymphoma.
11/2018	NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death.
11/2018	STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.
1/2018	A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
1/2018	Report of the 14th International Conference on Malignant Lymphoma (ICML) Closed Workshop on Future Design of Clinical Trials in Lymphomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anas Younes Research Topics

Disease

103	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2002
78	Neoplasms (Cancer) 01/2022 - 01/2002
74	Lymphoma (Lymphomas) 01/2022 - 12/2002
37	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2019 - 09/2003
27	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 11/2010
18	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2022 - 03/2003
15	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 12/2003
14	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 08/2003
12	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2016 - 12/2003
10	Neutropenia 10/2018 - 07/2005
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2019 - 10/2004
7	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 02/2008
6	Thrombocytopenia (Thrombopenia) 11/2018 - 11/2010
6	Disease Progression 10/2018 - 03/2004
6	Infections 12/2017 - 04/2005
6	Necrosis 03/2011 - 08/2003
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2015 - 05/2012
4	Febrile Neutropenia 12/2020 - 07/2005
4	Fatigue 11/2018 - 12/2013
4	Leukemia 02/2012 - 10/2004
3	Exanthema (Rash) 01/2022 - 09/2016
3	Melanoma (Melanoma, Malignant) 01/2021 - 08/2004
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 08/2008
3	Multiple Myeloma 08/2017 - 03/2004
3	Nausea 08/2017 - 03/2015
3	Anemia 08/2017 - 07/2005
2	Hypertension (High Blood Pressure) 01/2022 - 08/2017

Drug/Important Bio-Agent (IBA)

34	Rituximab (Mabthera)FDA Link 10/2022 - 07/2003
31	Brentuximab VedotinIBA 01/2022 - 11/2010
24	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2004
15	Monoclonal AntibodiesIBA 01/2022 - 03/2003
15	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
15	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2003
13	ibrutinibIBA 01/2022 - 08/2014
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 12/2004
11	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 11/2006
11	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 11/2006
11	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 12/2004
10	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 11/2006
10	PanobinostatIBA 11/2018 - 09/2010
10	Histone Deacetylase InhibitorsIBA 11/2018 - 11/2009
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
9	Prednisone (Sone)FDA LinkGeneric 01/2020 - 12/2004
9	LigandsIBA 10/2018 - 09/2003
9	Immunoconjugates (Immunoconjugate)IBA 01/2018 - 01/2007
8	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 04/2005
8	CytokinesIBA 05/2014 - 08/2003
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2002
7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2003
7	Bortezomib (Velcade)FDA Link 01/2018 - 05/2004
7	fludarabineIBA 01/2016 - 12/2002
6	NivolumabIBA 01/2021 - 01/2016
6	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 04/2005
5	AntigensIBA 01/2020 - 01/2007
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 11/2009
5	mocetinostatIBA 01/2017 - 09/2010
5	Biological ProductsIBA 07/2016 - 07/2005
5	AntibodiesIBA 01/2016 - 08/2005
5	Vorinostat FDA Link 07/2013 - 04/2008
5	tanespimycin (17AAG)IBA 05/2012 - 04/2005
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2007 - 04/2005
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 08/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2013
4	Phosphotransferases (Kinase)IBA 01/2018 - 08/2004
4	EnzymesIBA 11/2017 - 11/2009
4	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 04/2005
4	Gemcitabine FDA Link 01/2016 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 08/2003
4	NF-kappa B (NF-kB)IBA 03/2007 - 01/2002
3	B7-H1 AntigenIBA 01/2021 - 02/2016
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 08/2003
3	Pentostatin (Nipent)FDA LinkGeneric 01/2019 - 09/2003
3	Antisense OligonucleotidesIBA 11/2018 - 11/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 02/2006
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 03/2015
3	CUDC-907IBA 11/2017 - 01/2016
3	entinostat (MS 275)IBA 01/2016 - 09/2010
3	Protein Isoforms (Isoforms)IBA 01/2016 - 10/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 03/2006
3	InterferonsIBA 05/2012 - 07/2005
3	MTOR InhibitorsIBA 04/2012 - 07/2008
3	TOR Serine-Threonine KinasesIBA 11/2010 - 04/2008
3	temsirolimus FDA Link 11/2010 - 04/2008
3	Proteasome InhibitorsIBA 11/2010 - 05/2004
3	galiximabIBA 01/2007 - 03/2003
2	GalliumIBA 10/2022 - 06/2007
2	Bendamustine Hydrochloride FDA Link 10/2022 - 08/2017
2	NVP-BKM120IBA 01/2022 - 12/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 08/2005

Therapy/Procedure

71	Therapeutics 01/2022 - 12/2002
42	Drug Therapy (Chemotherapy) 10/2021 - 03/2002
23	Stem Cell Transplantation 01/2018 - 12/2002
8	Radiotherapy 10/2022 - 03/2002
5	Combination Drug Therapy (Combination Chemotherapy) 07/2016 - 09/2003
4	Immunotherapy 01/2021 - 02/2008
4	Aftercare (After-Treatment) 12/2013 - 07/2005
3	Drug Tapering 12/2020 - 05/2012
3	Precision Medicine 11/2019 - 10/2014
3	Salvage Therapy 01/2018 - 11/2014